The Perelman School of Medicine’s Michael Thase co-authored a study that found that patients experiencing depression were 30 percent more likely to respond well to treatments selected with guidance from genetic testing. “Having knowledge in improving the care of your patient is a good thing,” said Thase.

July 11, 2018 ・ From Philadelphia Inquirer